Hybridan

Our passion is raising growth capital for exciting, fast growth companies that want to take their business to the next level. We raise capital for companies both listed and unlisted in the most efficient manner possible and pride ourselves as being one of the few consistently profitable broking firms in the City. This has been achieved through a highly disciplined approach when seeking to create both corporate and institutional relationships.

Your Partner for Growth

Your Partner for Growth, Hybridan

Equity Bottom-Up

<ul>
<li>The UK-based biopharmaceutical Company developing regulatory approved, cannabinoid medicines to treat complex, chronic conditions, announced that trading in the Company's ordinary shares on the OTCQB Venture Market in the US will commence today.</li>
<li>There is no associated capital raise with this cross trade and the Ordinary Shares will continue to trade on the Company's primary listing market, the Apex segment of the Aquis Stock Exchange.</li>
<li>Cross trading on OTCQB allows the Company to access one of the world's largest investment markets to expand its reach into a broader pool of investors and build brand awareness in the most important pharmaceutical market in the world.</li>
</ul>


The UK-based biopharmaceutical Company developing regulatory approved, cannabinoid medicines to treat complex, chronic conditions, announced that trading in the Company's ordinary shares on the OTCQB Venture Market in the US will commence today.
There is no associated capital raise with this cross trade and the Ordinary Shares will continue to trade on the Company's primary listing market, the Apex segment of the Aquis Stock Exchange.
Cross trading on OTCQB allows the Company to access one of the world's largest investment markets to expand its reach into a broader pool of investors and build brand awareness in the most important pharmaceutical market in the world.


Ananda Pharma

Hybridan Small Cap Feast: 14/04/2025